These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29848613)

  • 1. Ability of Patients to Distinguish Among Cardiac Genomic Variant Subclassifications.
    Hellwig LD; Biesecker BB; Lewis KL; Biesecker LG; James CA; Klein WMP
    Circ Genom Precis Med; 2018 Jun; 11(6):e001975. PubMed ID: 29848613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disclosure of cardiac variants of uncertain significance results in an exome cohort.
    Lawal TA; Lewis KL; Johnston JJ; Heidlebaugh AR; Ng D; Gaston-Johansson FG; Klein WMP; Biesecker BB; Biesecker LG
    Clin Genet; 2018 May; 93(5):1022-1029. PubMed ID: 29383714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Interpretation of Sequence Variants.
    Zhang J; Yao Y; He H; Shen J
    Curr Protoc Hum Genet; 2020 Jun; 106(1):e98. PubMed ID: 32176464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant Classification Concordance using the ACMG-AMP Variant Interpretation Guidelines across Nine Genomic Implementation Research Studies.
    Amendola LM; Muenzen K; Biesecker LG; Bowling KM; Cooper GM; Dorschner MO; Driscoll C; Foreman AKM; Golden-Grant K; Greally JM; Hindorff L; Kanavy D; Jobanputra V; Johnston JJ; Kenny EE; McNulty S; Murali P; Ou J; Powell BC; Rehm HL; Rolf B; Roman TS; Van Ziffle J; Guha S; Abhyankar A; Crosslin D; Venner E; Yuan B; Zouk H; ; Jarvik GP
    Am J Hum Genet; 2020 Nov; 107(5):932-941. PubMed ID: 33108757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of 92 patient-driven family studies for reclassification of variants of uncertain significance.
    Tsai GJ; Rañola JMO; Smith C; Garrett LT; Bergquist T; Casadei S; Bowen DJ; Shirts BH
    Genet Med; 2019 Jun; 21(6):1435-1442. PubMed ID: 30374176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework.
    Tavtigian SV; Greenblatt MS; Harrison SM; Nussbaum RL; Prabhu SA; Boucher KM; Biesecker LG;
    Genet Med; 2018 Sep; 20(9):1054-1060. PubMed ID: 29300386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying the potential of functional evidence to reclassify variants of uncertain significance in the categorical and Bayesian interpretation frameworks.
    Brnich SE; Rivera-Muñoz EA; Berg JS
    Hum Mutat; 2018 Nov; 39(11):1531-1541. PubMed ID: 30095857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Utility of Reinterpreting Previously Reported Genomic Epilepsy Test Results for Pediatric Patients.
    SoRelle JA; Thodeson DM; Arnold S; Gotway G; Park JY
    JAMA Pediatr; 2019 Jan; 173(1):e182302. PubMed ID: 30398534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants.
    Lee K; Krempely K; Roberts ME; Anderson MJ; Carneiro F; Chao E; Dixon K; Figueiredo J; Ghosh R; Huntsman D; Kaurah P; Kesserwan C; Landrith T; Li S; Mensenkamp AR; Oliveira C; Pardo C; Pesaran T; Richardson M; Slavin TP; Spurdle AB; Trapp M; Witkowski L; Yi CS; Zhang L; Plon SE; Schrader KA; Karam R
    Hum Mutat; 2018 Nov; 39(11):1553-1568. PubMed ID: 30311375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
    Kurian AW; Ward KC; Hamilton AS; Deapen DM; Abrahamse P; Bondarenko I; Li Y; Hawley ST; Morrow M; Jagsi R; Katz SJ
    JAMA Oncol; 2018 Aug; 4(8):1066-1072. PubMed ID: 29801090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.
    Waldmüller S; Schroeder C; Sturm M; Scheffold T; Imbrich K; Junker S; Frische C; Hofbeck M; Bauer P; Bonin M; Gawaz M; Gramlich M
    Mol Cell Probes; 2015 Oct; 29(5):308-14. PubMed ID: 25979592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
    Tsaousis GN; Papadopoulou E; Apessos A; Agiannitopoulos K; Pepe G; Kampouri S; Diamantopoulos N; Floros T; Iosifidou R; Katopodi O; Koumarianou A; Markopoulos C; Papazisis K; Venizelos V; Xanthakis I; Xepapadakis G; Banu E; Eniu DT; Negru S; Stanculeanu DL; Ungureanu A; Ozmen V; Tansan S; Tekinel M; Yalcin S; Nasioulas G
    BMC Cancer; 2019 Jun; 19(1):535. PubMed ID: 31159747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.
    Balmaña J; Digiovanni L; Gaddam P; Walsh MF; Joseph V; Stadler ZK; Nathanson KL; Garber JE; Couch FJ; Offit K; Robson ME; Domchek SM
    J Clin Oncol; 2016 Dec; 34(34):4071-4078. PubMed ID: 27621404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing.
    Mersch J; Brown N; Pirzadeh-Miller S; Mundt E; Cox HC; Brown K; Aston M; Esterling L; Manley S; Ross T
    JAMA; 2018 Sep; 320(12):1266-1274. PubMed ID: 30264118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Variant Classification: A Comparison of Public Databases and a Commercial Testing Laboratory.
    Gradishar W; Johnson K; Brown K; Mundt E; Manley S
    Oncologist; 2017 Jul; 22(7):797-803. PubMed ID: 28408614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Navigating the nuances of clinical sequence variant interpretation in Mendelian disease.
    Strande NT; Brnich SE; Roman TS; Berg JS
    Genet Med; 2018 Sep; 20(9):918-926. PubMed ID: 29988079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of 4 years of molecular genetic diagnosis on a panel of genes involved in premature aging syndromes, including laminopathies and related disorders.
    Grelet M; Blanck V; Sigaudy S; Philip N; Giuliano F; Khachnaoui K; Morel G; Grotto S; Sophie J; Poirsier C; Lespinasse J; Alric L; Calvas P; Chalhoub G; Layet V; Molin A; Colson C; Marsili L; Edery P; Lévy N; De Sandre-Giovannoli A
    Orphanet J Rare Dis; 2019 Dec; 14(1):288. PubMed ID: 31829210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Variant Findings and Challenges Associated With the Clinical Integration of Genomic Testing: An Interim Report of the Genomic Medicine for Ill Neonates and Infants (GEMINI) Study.
    Maron JL; Kingsmore SF; Wigby K; Chowdhury S; Dimmock D; Poindexter B; Suhrie K; Vockley J; Diacovo T; Gelb BD; Stroustrup A; Powell CM; Trembath A; Gallen M; Mullen TE; Tanpaiboon P; Reed D; Kurfiss A; Davis JM
    JAMA Pediatr; 2021 May; 175(5):e205906. PubMed ID: 33587123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A machine learning approach based on ACMG/AMP guidelines for genomic variant classification and prioritization.
    Nicora G; Zucca S; Limongelli I; Bellazzi R; Magni P
    Sci Rep; 2022 Feb; 12(1):2517. PubMed ID: 35169226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole Genome Sequencing Improves Outcomes of Genetic Testing in Patients With Hypertrophic Cardiomyopathy.
    Bagnall RD; Ingles J; Dinger ME; Cowley MJ; Ross SB; Minoche AE; Lal S; Turner C; Colley A; Rajagopalan S; Berman Y; Ronan A; Fatkin D; Semsarian C
    J Am Coll Cardiol; 2018 Jul; 72(4):419-429. PubMed ID: 30025578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.